Why it matters: Though the FDA said it should not be considered a vaccine substitute, the monoclonal antibodies can protect against severe illness by overwhelming the infection before it leaves the nose and throat, according to researchers.
Stay on top of the latest market trends and economic insights with Axios Markets.
UK
Australia
France
Germany
Russia
India
Canada